Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-12-045487
Filing Date
2012-08-14
Accepted
2012-08-14 17:05:39
Documents
1
Period of Report
2012-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd352978.html 3  
1 FORM 3 rrd352978.xml 3 8229
  Complete submission text file 0001181431-12-045487.txt   10879
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LEVEL 5 71 COLLINS ST MELBOURNE C3 VIC 3000
Business Address LEVEL 5 71 COLLINS ST MELBOURNE C3 VIC 3000 61386509921
GBS Bioventures II A/C (Reporting) CIK: 0001542843 (see all company filings)

State of Incorp.: C3 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-54735 | Film No.: 121034100

Mailing Address LEVEL 5 71 COLLINS ST MELBOURNE C3 VIC 3000
Business Address LEVEL 5 71 COLLINS ST MELBOURNE C3 VIC 3000 61386509921
GBS Venture Partners Pty, Ltd (Reporting) CIK: 0001542845 (see all company filings)

State of Incorp.: C3 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-54735 | Film No.: 121034101

Mailing Address LEVEL 5, 71 COLLINS STREET MELBOURNE VICTORIA C3 3000
Business Address LEVEL 5, 71 COLLINS STREET MELBOURNE VICTORIA C3 3000 650-577-6717
Genesis Fund (Reporting) CIK: 0001556185 (see all company filings)

Fiscal Year End: 0630
Type: 3 | Act: 34 | File No.: 000-54735 | Film No.: 121034102